GSE135016
A tumor specific super-enhancer drives immune evasion by guiding synchronous expression of PD-L1 and PD-L2
A tumor specific super-enhancer drives immune evasion by guiding synchronous expression of PD-L1 and PD-L2 Overall design: RNA-seq of SgVec and PD-L1L2-SE deficient SUM-159 cells.